rabbit anti p foxo1 s256 Search Results


96
Cell Signaling Technology Inc phospho foxo1 s256
Evaluation of GSK-3β, <t>FOXO1,</t> and FOXO3 phosphorylation levels following proteasome inhibition. ( A ) Representative western blot images of P(S9)-GSK-3β, total GSK-3β, and actin as loading control, following proteasome inhibition. The graph shows the quantification of P(S9)-GSK-3β/GSK-3β ratio. ( B ) Representative western blot images of <t>P(S256)-FOXO1,</t> FOXO1, and graphs showing the quantification of P(S256)-FOXO1 and FOXO1 following proteasome inhibition. ( C ) The same as in ( B ) but for P(S253)-FOXO3 and FOXO3. Actin was included as loading control. The data are expressed as the mean percentage of the ratio of the optical density (OD) normalized to the control. Experiments were repeated at least three times. Statistical significance * p < 0.05 and ** p < 0.01.
Phospho Foxo1 S256, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/Phospho-FoxO1+(Ser256)+Antibody/pmc11674117-52-39-41
Average 96 stars, based on 1 article reviews
phospho foxo1 s256 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

92
ABclonal Biotechnology antibodies against phospho foxo1
Evaluation of GSK-3β, <t>FOXO1,</t> and FOXO3 phosphorylation levels following proteasome inhibition. ( A ) Representative western blot images of P(S9)-GSK-3β, total GSK-3β, and actin as loading control, following proteasome inhibition. The graph shows the quantification of P(S9)-GSK-3β/GSK-3β ratio. ( B ) Representative western blot images of <t>P(S256)-FOXO1,</t> FOXO1, and graphs showing the quantification of P(S256)-FOXO1 and FOXO1 following proteasome inhibition. ( C ) The same as in ( B ) but for P(S253)-FOXO3 and FOXO3. Actin was included as loading control. The data are expressed as the mean percentage of the ratio of the optical density (OD) normalized to the control. Experiments were repeated at least three times. Statistical significance * p < 0.05 and ** p < 0.01.
Antibodies Against Phospho Foxo1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/Phospho-FoxO1-S256+Rabbit+pAb/pmc11946502-208-0-12
Average 92 stars, based on 1 article reviews
antibodies against phospho foxo1 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Bioss anti phospho foxo1 s256 polyclonal
(a) Representative histogram of CFSE dilution for T reg suppression assay. Yellow; Foxp3 Cre Teff only, Blue; Foxp3 Cre T reg cells and Foxp3 Cre Teff at 1:1 ratio, Red; Ctnnb1 ΔEx3/ Foxp3 Cre T reg cells and Foxp3 Cre Teff at 1:1 ratio (left). Bar graph shows percentage of suppression (right) (n=3). P values were calculated by two-sided Student’s t -test. (b) Gene expression profile of Foxp3 Cre and Ctnnb1 ΔEx3/ Foxp3 Cre T reg cells by microarray analysis. (c) Flow cytometric analysis on peripheral lymph node T reg cells from Foxp3 Cre and Ctnnb1 ΔEx3/ Foxp3 Cre mice. Quantification of gMFI for indicated molecules was shown ( Foxp3 Cre; n=4 mice, Ctnnb1 ΔEx3/ Foxp3 Cre; n=4 or 5 mice). P values were calculated by two-sided Student’s t -test. Data were represented as mean and mean +/− SD. (d) Representative immunofluorescence images of human T reg cells with PLA signal for <t>β-catenin-Foxo1</t> interaction (red) and Foxp3 staining (green). Nuclei were stained with DAPI (blue). Scale bar; 5μM. Data were representative of three experiments.
Anti Phospho Foxo1 S256 Polyclonal, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/FoxO1+(Ser256)+Polyclonal+Antibody/pmc06240373-198-40-49
Average 93 stars, based on 1 article reviews
anti phospho foxo1 s256 polyclonal - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc s256
1,25(OH) 2 D 3 deficiency leads to increased gluconeogenesis and hepatic insulin resistance through impairing phosphorylation of AKT and phosphorylation of FOXO1. (a) ITT was performed in 6-month-old 1 α (OH)ase −/− and wild-type mice ( n = 8). ns: not significant; blue line: RDWT group; red line: RDKO group; black bar: RDWT group; gray bar: RDKO group. (b, c) Insulin stimulated the phosphorylation of AKT-S473 and <t>FOXO1-S256</t> in wild-type livers markedly but failed to do so in the mutant ones, as measured by Western blotting (b) and IHC (c). ∗ P < 0.05. Scale bar = 100 μ m; magnification: 20x (c). (d) The phosphorylation of AKT-S473 and FOXO1-S256 was also inhibited in HepG2 cells transfected with si-VDR compared with HepG2 cells transfected with si-NC. ∗ P < 0.05. (e) Ectopic overexpression of FOXO1 increases transcriptional activity of PCK1 promoter. This effect was enhanced by knockdown of VDR. HepG2 cells were transfected with PCK1-luc, together with a FOXO1 expression vector (FOXO1) or a GFP expression vector as a control (GFP). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.
S256, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/Phospho-FoxO1+(Ser256)+Rabbit+mAb/pmc08817869-50-27-28
Average 93 stars, based on 1 article reviews
s256 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc cat 2997t c77d7 rabbit anti phospho foxo1 s256
1,25(OH) 2 D 3 deficiency leads to increased gluconeogenesis and hepatic insulin resistance through impairing phosphorylation of AKT and phosphorylation of FOXO1. (a) ITT was performed in 6-month-old 1 α (OH)ase −/− and wild-type mice ( n = 8). ns: not significant; blue line: RDWT group; red line: RDKO group; black bar: RDWT group; gray bar: RDKO group. (b, c) Insulin stimulated the phosphorylation of AKT-S473 and <t>FOXO1-S256</t> in wild-type livers markedly but failed to do so in the mutant ones, as measured by Western blotting (b) and IHC (c). ∗ P < 0.05. Scale bar = 100 μ m; magnification: 20x (c). (d) The phosphorylation of AKT-S473 and FOXO1-S256 was also inhibited in HepG2 cells transfected with si-VDR compared with HepG2 cells transfected with si-NC. ∗ P < 0.05. (e) Ectopic overexpression of FOXO1 increases transcriptional activity of PCK1 promoter. This effect was enhanced by knockdown of VDR. HepG2 cells were transfected with PCK1-luc, together with a FOXO1 expression vector (FOXO1) or a GFP expression vector as a control (GFP). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.
Cat 2997t C77d7 Rabbit Anti Phospho Foxo1 S256, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/Phospho-PRAS40+(Thr246)+Rabbit+mAb/pmc06245953__NIHMS1500485___supplement___2-38-116-123
Average 95 stars, based on 1 article reviews
cat 2997t c77d7 rabbit anti phospho foxo1 s256 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc antibodies against foxo1
Figure 1. <t>FoxO1</t> expression in placentas of human and mouse. (A) FoxO1 immunohistochemistry staining in human term placenta. Red arrow: endothelial cells in villi; black arrow: cytotrophoblasts in villi; green arrow, spiral artery endothelial cells; yellow arrow, endometrial stromal cells. (B) Immunohistochemistry staining of FoxO1 in mice placentas at E10.5, E12.5, E14.5, E16.5, and term. Red lines indicate the borderline of different layers in the placenta; green arrows indicate FoxO1-positive signals. D, maternal decidua; JZ, junctional zone; LZ, labyrinth.
Antibodies Against Foxo1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/FoxO1+Rabbit+mAb/pm36748194-35-1-14
Average 96 stars, based on 1 article reviews
antibodies against foxo1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti p foxo1
Figure 1. <t>FoxO1</t> expression in placentas of human and mouse. (A) FoxO1 immunohistochemistry staining in human term placenta. Red arrow: endothelial cells in villi; black arrow: cytotrophoblasts in villi; green arrow, spiral artery endothelial cells; yellow arrow, endometrial stromal cells. (B) Immunohistochemistry staining of FoxO1 in mice placentas at E10.5, E12.5, E14.5, E16.5, and term. Red lines indicate the borderline of different layers in the placenta; green arrows indicate FoxO1-positive signals. D, maternal decidua; JZ, junctional zone; LZ, labyrinth.
Anti P Foxo1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/FoxO1+(L27)+Antibody/pm28710921-68-12-26
Average 95 stars, based on 1 article reviews
anti p foxo1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
ABclonal Biotechnology antiphospho foxo1
Figure 1. <t>FoxO1</t> expression in placentas of human and mouse. (A) FoxO1 immunohistochemistry staining in human term placenta. Red arrow: endothelial cells in villi; black arrow: cytotrophoblasts in villi; green arrow, spiral artery endothelial cells; yellow arrow, endometrial stromal cells. (B) Immunohistochemistry staining of FoxO1 in mice placentas at E10.5, E12.5, E14.5, E16.5, and term. Red lines indicate the borderline of different layers in the placenta; green arrows indicate FoxO1-positive signals. D, maternal decidua; JZ, junctional zone; LZ, labyrinth.
Antiphospho Foxo1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/Phospho-FoxO1-S256+Antibody+kit/pm41013182-92-47-49
Average 93 stars, based on 1 article reviews
antiphospho foxo1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc pfoxo1 s256
Figure 1. <t>FoxO1</t> expression in placentas of human and mouse. (A) FoxO1 immunohistochemistry staining in human term placenta. Red arrow: endothelial cells in villi; black arrow: cytotrophoblasts in villi; green arrow, spiral artery endothelial cells; yellow arrow, endometrial stromal cells. (B) Immunohistochemistry staining of FoxO1 in mice placentas at E10.5, E12.5, E14.5, E16.5, and term. Red lines indicate the borderline of different layers in the placenta; green arrows indicate FoxO1-positive signals. D, maternal decidua; JZ, junctional zone; LZ, labyrinth.
Pfoxo1 S256, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/Sin1+Rabbit+mAb/pm28934384-187-14-23
Average 94 stars, based on 1 article reviews
pfoxo1 s256 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc foxo1
A : Pancreas sections stained for insulin (green) and glucagon (red). B-E : Bulk RNA sequencing of islets isolated from Control ( Irs2+/+ ; Cdk4 - wt/wt) , Diabetic (Irs2 - /- ; Cdk4 - wt/wt) , and Rescue ( Irs2 - /- ; Cdk4 - R24C/R24C) genotypes. Principal component analysis showed clean partitioning of the genotypes ( C ). K-means clustering ( D ) revealed three clusters in which mRNA abundance was disrupted during decompensation (Diabetic) and partially recovered in (Rescue). Cluster E, containing genes that were reduced in Irs2 - /- ; Cdk4 - wt/wt (Diabetic) mice and partially restored in Irs2 - /- ; Cdk4 - R24C/R24C (Rescue) mice, shown in the heat map in ( E ) mapped to a single GO term: Regulation of insulin secretion. F-H : Pancreas sections immunostained for insulin (green), dapi (blue) and ALDH1A3 ( F ), <t>FOXO1</t> ( G ) or PDX1 ( H ) (red) confirm beta cell dedifferentiation signature in Irs2-/- male mice was rescued by homozygous Cdk4-R24C . Greyscale insets reflect red channel immunofluorescence in F-H .
Foxo1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/Raptor+Rabbit+mAb/bio_rxiv__2022__10__19__512511-245-8-10
Average 96 stars, based on 1 article reviews
foxo1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

91
Bioss akt1(thr34) polyclonal antibody
A : Pancreas sections stained for insulin (green) and glucagon (red). B-E : Bulk RNA sequencing of islets isolated from Control ( Irs2+/+ ; Cdk4 - wt/wt) , Diabetic (Irs2 - /- ; Cdk4 - wt/wt) , and Rescue ( Irs2 - /- ; Cdk4 - R24C/R24C) genotypes. Principal component analysis showed clean partitioning of the genotypes ( C ). K-means clustering ( D ) revealed three clusters in which mRNA abundance was disrupted during decompensation (Diabetic) and partially recovered in (Rescue). Cluster E, containing genes that were reduced in Irs2 - /- ; Cdk4 - wt/wt (Diabetic) mice and partially restored in Irs2 - /- ; Cdk4 - R24C/R24C (Rescue) mice, shown in the heat map in ( E ) mapped to a single GO term: Regulation of insulin secretion. F-H : Pancreas sections immunostained for insulin (green), dapi (blue) and ALDH1A3 ( F ), <t>FOXO1</t> ( G ) or PDX1 ( H ) (red) confirm beta cell dedifferentiation signature in Irs2-/- male mice was rescued by homozygous Cdk4-R24C . Greyscale insets reflect red channel immunofluorescence in F-H .
Akt1(thr34) Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+p+foxo1+s256/AKT1(Thr34)+Polyclonal+Antibody/custom%40bs-5194r%408817869
Average 91 stars, based on 1 article reviews
akt1(thr34) polyclonal antibody - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

Image Search Results


Evaluation of GSK-3β, FOXO1, and FOXO3 phosphorylation levels following proteasome inhibition. ( A ) Representative western blot images of P(S9)-GSK-3β, total GSK-3β, and actin as loading control, following proteasome inhibition. The graph shows the quantification of P(S9)-GSK-3β/GSK-3β ratio. ( B ) Representative western blot images of P(S256)-FOXO1, FOXO1, and graphs showing the quantification of P(S256)-FOXO1 and FOXO1 following proteasome inhibition. ( C ) The same as in ( B ) but for P(S253)-FOXO3 and FOXO3. Actin was included as loading control. The data are expressed as the mean percentage of the ratio of the optical density (OD) normalized to the control. Experiments were repeated at least three times. Statistical significance * p < 0.05 and ** p < 0.01.

Journal: Cells

Article Title: Distinct UPR and Autophagic Functions Define Cell-Specific Responses to Proteotoxic Stress in Microglial and Neuronal Cell Lines

doi: 10.3390/cells13242069

Figure Lengend Snippet: Evaluation of GSK-3β, FOXO1, and FOXO3 phosphorylation levels following proteasome inhibition. ( A ) Representative western blot images of P(S9)-GSK-3β, total GSK-3β, and actin as loading control, following proteasome inhibition. The graph shows the quantification of P(S9)-GSK-3β/GSK-3β ratio. ( B ) Representative western blot images of P(S256)-FOXO1, FOXO1, and graphs showing the quantification of P(S256)-FOXO1 and FOXO1 following proteasome inhibition. ( C ) The same as in ( B ) but for P(S253)-FOXO3 and FOXO3. Actin was included as loading control. The data are expressed as the mean percentage of the ratio of the optical density (OD) normalized to the control. Experiments were repeated at least three times. Statistical significance * p < 0.05 and ** p < 0.01.

Article Snippet: Membranes were blocked and then incubated overnight at 4 °C with the following primary antibodies: (i) rabbit polyclonal antibodies against Akt, phospho-Akt (T308), phospho-Akt (S473), cleaved caspase-3, LC3B, phospho-GSK-3β (S9), GRP78, poly-ubiquitin, SQSTM1/p62, and phospho-SQSTM1/p62 (S403), phospho-FOXO3 (S253), and phospho-FOXO1 (S256) (Cell Signaling, Danvers, MA, USA); XBP1 (abcam, Cambridge, UK); (ii) mouse monoclonal antibodies against β-actin (Sigma-Aldrich), β-catenin, and phospho-β-catenin (S33/37/T41), CHOP, FOXO3, FOXO1 (Cell Signaling, Danvers, MA, USA); GSK3-clone 4G-1E (Millipore, Madrid, Spain).

Techniques: Phospho-proteomics, Inhibition, Western Blot, Control

Summary of the cell-specific responses to proteasome inhibition observed in BV2 and N2a cells. In BV2 cells, proteasome inhibition (PI) weakly activates the IRE1α-sXbp1 arm but predominantly triggers the pro-apoptotic PERK-CHOP pathway. Additionally, there is a prominent induction of the mTORC2-AKT-FOXO1-β-catenin pathway, potentially leading to LC3-associated phagocytosis (LAP) and subsequent cell death, which probably stimulates phagocytosis, leading to additional cell death. In N2a cells, PI activates the canonical UPR with predominance of the IRE1α-sXbp1 arm. Simultaneously, it triggers the PDK1-AKT-FOXO3 axis, stimulating autophagy for proteostasis restoration. According to present data, we propose that autophagy appears to play a role in restoring cellular proteostasis in neurons while regulating phagocytosis in microglial cells, likely mediated by differential Akt and p62 phosphorylation levels leading finally to cell survival or cell death.

Journal: Cells

Article Title: Distinct UPR and Autophagic Functions Define Cell-Specific Responses to Proteotoxic Stress in Microglial and Neuronal Cell Lines

doi: 10.3390/cells13242069

Figure Lengend Snippet: Summary of the cell-specific responses to proteasome inhibition observed in BV2 and N2a cells. In BV2 cells, proteasome inhibition (PI) weakly activates the IRE1α-sXbp1 arm but predominantly triggers the pro-apoptotic PERK-CHOP pathway. Additionally, there is a prominent induction of the mTORC2-AKT-FOXO1-β-catenin pathway, potentially leading to LC3-associated phagocytosis (LAP) and subsequent cell death, which probably stimulates phagocytosis, leading to additional cell death. In N2a cells, PI activates the canonical UPR with predominance of the IRE1α-sXbp1 arm. Simultaneously, it triggers the PDK1-AKT-FOXO3 axis, stimulating autophagy for proteostasis restoration. According to present data, we propose that autophagy appears to play a role in restoring cellular proteostasis in neurons while regulating phagocytosis in microglial cells, likely mediated by differential Akt and p62 phosphorylation levels leading finally to cell survival or cell death.

Article Snippet: Membranes were blocked and then incubated overnight at 4 °C with the following primary antibodies: (i) rabbit polyclonal antibodies against Akt, phospho-Akt (T308), phospho-Akt (S473), cleaved caspase-3, LC3B, phospho-GSK-3β (S9), GRP78, poly-ubiquitin, SQSTM1/p62, and phospho-SQSTM1/p62 (S403), phospho-FOXO3 (S253), and phospho-FOXO1 (S256) (Cell Signaling, Danvers, MA, USA); XBP1 (abcam, Cambridge, UK); (ii) mouse monoclonal antibodies against β-actin (Sigma-Aldrich), β-catenin, and phospho-β-catenin (S33/37/T41), CHOP, FOXO3, FOXO1 (Cell Signaling, Danvers, MA, USA); GSK3-clone 4G-1E (Millipore, Madrid, Spain).

Techniques: Inhibition, Phospho-proteomics

(a) Representative histogram of CFSE dilution for T reg suppression assay. Yellow; Foxp3 Cre Teff only, Blue; Foxp3 Cre T reg cells and Foxp3 Cre Teff at 1:1 ratio, Red; Ctnnb1 ΔEx3/ Foxp3 Cre T reg cells and Foxp3 Cre Teff at 1:1 ratio (left). Bar graph shows percentage of suppression (right) (n=3). P values were calculated by two-sided Student’s t -test. (b) Gene expression profile of Foxp3 Cre and Ctnnb1 ΔEx3/ Foxp3 Cre T reg cells by microarray analysis. (c) Flow cytometric analysis on peripheral lymph node T reg cells from Foxp3 Cre and Ctnnb1 ΔEx3/ Foxp3 Cre mice. Quantification of gMFI for indicated molecules was shown ( Foxp3 Cre; n=4 mice, Ctnnb1 ΔEx3/ Foxp3 Cre; n=4 or 5 mice). P values were calculated by two-sided Student’s t -test. Data were represented as mean and mean +/− SD. (d) Representative immunofluorescence images of human T reg cells with PLA signal for β-catenin-Foxo1 interaction (red) and Foxp3 staining (green). Nuclei were stained with DAPI (blue). Scale bar; 5μM. Data were representative of three experiments.

Journal: Nature immunology

Article Title: Activated β-Catenin in Foxp3 + Regulatory T cells Links Inflammatory Environments to Autoimmunity

doi: 10.1038/s41590-018-0236-6

Figure Lengend Snippet: (a) Representative histogram of CFSE dilution for T reg suppression assay. Yellow; Foxp3 Cre Teff only, Blue; Foxp3 Cre T reg cells and Foxp3 Cre Teff at 1:1 ratio, Red; Ctnnb1 ΔEx3/ Foxp3 Cre T reg cells and Foxp3 Cre Teff at 1:1 ratio (left). Bar graph shows percentage of suppression (right) (n=3). P values were calculated by two-sided Student’s t -test. (b) Gene expression profile of Foxp3 Cre and Ctnnb1 ΔEx3/ Foxp3 Cre T reg cells by microarray analysis. (c) Flow cytometric analysis on peripheral lymph node T reg cells from Foxp3 Cre and Ctnnb1 ΔEx3/ Foxp3 Cre mice. Quantification of gMFI for indicated molecules was shown ( Foxp3 Cre; n=4 mice, Ctnnb1 ΔEx3/ Foxp3 Cre; n=4 or 5 mice). P values were calculated by two-sided Student’s t -test. Data were represented as mean and mean +/− SD. (d) Representative immunofluorescence images of human T reg cells with PLA signal for β-catenin-Foxo1 interaction (red) and Foxp3 staining (green). Nuclei were stained with DAPI (blue). Scale bar; 5μM. Data were representative of three experiments.

Article Snippet: Antibodies and reagents used for flow cytometric analysis are listed as follows: for human samples; anti-CD4 (RPA-T4), anti-CD25 (MA251), anti-CD127 (HIL-7R-M21), anti-CD45RO (UCHL1), anti-IFN-γ (B27), anti-β-catenin (14/Beta-Catenin), anti-TCF1 (S33–966), PE-Cy™7 Streptavidin from BD Bioscience, anti-IL-10 (JES3–9D7), anti-Tbet (4B10) from BioLegend, anti-phospho Foxo1 (S256) polyclonal, anti-phospho SGK1 (T256) polyclonal (from Bioss), anti-phospho β-catenin (Ser522) (D8E11), anti-phospho AKT (Ser473) (D9E), anti-phospho GSK3β (Ser9) (D85E12), anti-Foxo1 (C29H4) from CST, anti-IFN-γ (4S.B3), anti-Foxp3 (PCH101) from eBioscience, anti-active β-catenin (8E7) from Millipore, IFN-γ secretion assay (APC), IL-10 secretion assay (PE) from Miltenyi, for mice samples; anti-Foxp3 (FJK-16s), anti-CD3 (145–2C11), anti-CD4 (RM4–5), anti-CD8 (53–6.7), anti-GATA3 (TWAJ), anti-RORgt (B2D) from eBioscience, anti-Helios (22F6) from BioLegend, anti-phospho Foxo1 (S256) (E1F7T), anti-phospho Foxo3a (Ser253) (D18H8), anti-phospho Foxo1(T24)/3a(T32)/4(T28) (4G6) from CST, anti-SGK1 (Y238) (from Abcam), for both human and mice samples; Zombie Aqua™ Fixable Viability dye from BioLegend.

Techniques: Suppression Assay, Expressing, Microarray, Immunofluorescence, Staining

(a) Flow cytometric analysis of Active β-catenin, p-SGK1 (Thr256), and p-Foxo1 (Ser256) expression in human IFN-γ-producing T reg cells. T reg cells were stimulated with anti-CD3 and anti-CD28 in the presence (NaCl) or absence (Control) of additional 40 mM NaCl for 96 h followed by 4 h PMA plus iomomycin stimulation (Active β-catenin; n=18 subjects, p-SGK1; n=13 subjects, p-Foxo1; n=10 subjects). P values were calculated by two-sided Student’s t -test. (b) mRNA expression kinetics for Wnt-β-catenin target genes ( AXIN2 and TCF7 ) from nine time points were plotted and each dots represent the average of four different experiments. * P <0.05, ** P <0.01, *** P <0.001 (two-way ANOVA with Sidak’s multiple comparisons test). Data were represented as mean +/− SEM. (c) IFNG mRNA expression in human T reg cells cultured in T H 0 or T H 1 condition in the presence (NaCl) or absence (Control) of additional 40 mM NaCl for 96 h (n=19 subjects). * P <0.05, ** P <0.01, *** P <0.001 (one-way ANOVA with Tukey’s multiple comparisons test). (d) IFNG mRNA expression in human T reg cells stimulated in the presence (NaCl) or absence (Control) of additional 40 mM NaCl with and without Wnt/inhibitor PKF115–584 (PKF) or IWR-1 (IWR) for 96 h (n=7–10 subjects). * P <0.05 (one-way ANOVA with Tukey’s multiple comparisons test). (e) Representative flow cytometric analysis of IFN-γ and IL-10 production in human T reg cells transduced with a non-targeted shRNA or a CTNNB1 shRNA and cultured in the normal media (Control) or media supplemented with additional 40 mM NaCl (NaCl) for 96 h. Data are representative of three experiments. (f) IFNG and IL10 mRNA expression on T reg cells, and (g) frequency of IFN-γ and IL-1 0 producing T reg cells relative to control/scramble shRNA condition were shown. T reg cells were treated as in (e) ( f ; n=9 subjects, g ; n=8 subjects). * P <0.05, ** P <0.01, *** P <0.001 (one-way ANOVA with Tukey’s multiple comparisons test). Data were represented as mean +/− SD.

Journal: Nature immunology

Article Title: Activated β-Catenin in Foxp3 + Regulatory T cells Links Inflammatory Environments to Autoimmunity

doi: 10.1038/s41590-018-0236-6

Figure Lengend Snippet: (a) Flow cytometric analysis of Active β-catenin, p-SGK1 (Thr256), and p-Foxo1 (Ser256) expression in human IFN-γ-producing T reg cells. T reg cells were stimulated with anti-CD3 and anti-CD28 in the presence (NaCl) or absence (Control) of additional 40 mM NaCl for 96 h followed by 4 h PMA plus iomomycin stimulation (Active β-catenin; n=18 subjects, p-SGK1; n=13 subjects, p-Foxo1; n=10 subjects). P values were calculated by two-sided Student’s t -test. (b) mRNA expression kinetics for Wnt-β-catenin target genes ( AXIN2 and TCF7 ) from nine time points were plotted and each dots represent the average of four different experiments. * P <0.05, ** P <0.01, *** P <0.001 (two-way ANOVA with Sidak’s multiple comparisons test). Data were represented as mean +/− SEM. (c) IFNG mRNA expression in human T reg cells cultured in T H 0 or T H 1 condition in the presence (NaCl) or absence (Control) of additional 40 mM NaCl for 96 h (n=19 subjects). * P <0.05, ** P <0.01, *** P <0.001 (one-way ANOVA with Tukey’s multiple comparisons test). (d) IFNG mRNA expression in human T reg cells stimulated in the presence (NaCl) or absence (Control) of additional 40 mM NaCl with and without Wnt/inhibitor PKF115–584 (PKF) or IWR-1 (IWR) for 96 h (n=7–10 subjects). * P <0.05 (one-way ANOVA with Tukey’s multiple comparisons test). (e) Representative flow cytometric analysis of IFN-γ and IL-10 production in human T reg cells transduced with a non-targeted shRNA or a CTNNB1 shRNA and cultured in the normal media (Control) or media supplemented with additional 40 mM NaCl (NaCl) for 96 h. Data are representative of three experiments. (f) IFNG and IL10 mRNA expression on T reg cells, and (g) frequency of IFN-γ and IL-1 0 producing T reg cells relative to control/scramble shRNA condition were shown. T reg cells were treated as in (e) ( f ; n=9 subjects, g ; n=8 subjects). * P <0.05, ** P <0.01, *** P <0.001 (one-way ANOVA with Tukey’s multiple comparisons test). Data were represented as mean +/− SD.

Article Snippet: Antibodies and reagents used for flow cytometric analysis are listed as follows: for human samples; anti-CD4 (RPA-T4), anti-CD25 (MA251), anti-CD127 (HIL-7R-M21), anti-CD45RO (UCHL1), anti-IFN-γ (B27), anti-β-catenin (14/Beta-Catenin), anti-TCF1 (S33–966), PE-Cy™7 Streptavidin from BD Bioscience, anti-IL-10 (JES3–9D7), anti-Tbet (4B10) from BioLegend, anti-phospho Foxo1 (S256) polyclonal, anti-phospho SGK1 (T256) polyclonal (from Bioss), anti-phospho β-catenin (Ser522) (D8E11), anti-phospho AKT (Ser473) (D9E), anti-phospho GSK3β (Ser9) (D85E12), anti-Foxo1 (C29H4) from CST, anti-IFN-γ (4S.B3), anti-Foxp3 (PCH101) from eBioscience, anti-active β-catenin (8E7) from Millipore, IFN-γ secretion assay (APC), IL-10 secretion assay (PE) from Miltenyi, for mice samples; anti-Foxp3 (FJK-16s), anti-CD3 (145–2C11), anti-CD4 (RM4–5), anti-CD8 (53–6.7), anti-GATA3 (TWAJ), anti-RORgt (B2D) from eBioscience, anti-Helios (22F6) from BioLegend, anti-phospho Foxo1 (S256) (E1F7T), anti-phospho Foxo3a (Ser253) (D18H8), anti-phospho Foxo1(T24)/3a(T32)/4(T28) (4G6) from CST, anti-SGK1 (Y238) (from Abcam), for both human and mice samples; Zombie Aqua™ Fixable Viability dye from BioLegend.

Techniques: Expressing, Cell Culture, Transduction, shRNA

(a) Flow cytometric analysis of T reg cells from the mesenteric lymph nodes of wild type mice fed a normal diet (ND) or a high-salt diet (HSD) for 3 weeks. Quantification of gMFI for β-catenin and p-Foxo1/3a/4 were shown (ND; n=4, HSD; n=4). P values were calculated by two-sided Student’s t -test. (b) Flow cytometric analysis of ABC level in ex vivo T reg s of healthy controls and MS patients (HC; n=14 subjects, MS; n=11 subjects). P value was calculated by two-sided Student’s t -test. Data were represented as mean +/− SD. (c-e) Correlation plots (c); between the percentage of IFN-γ−producing T reg cells and gMFI of Active β-catenin, (d); between IFNG and PTGER2 mRNA expression, (e); between Active β-catenin level and PTGER2 mRNA expression level in healthy subjects and MS patients. Linear regression is shown with 95% confidence interval (dotted lines). Correlation statistics by two-sided Spearman rank correlation test.

Journal: Nature immunology

Article Title: Activated β-Catenin in Foxp3 + Regulatory T cells Links Inflammatory Environments to Autoimmunity

doi: 10.1038/s41590-018-0236-6

Figure Lengend Snippet: (a) Flow cytometric analysis of T reg cells from the mesenteric lymph nodes of wild type mice fed a normal diet (ND) or a high-salt diet (HSD) for 3 weeks. Quantification of gMFI for β-catenin and p-Foxo1/3a/4 were shown (ND; n=4, HSD; n=4). P values were calculated by two-sided Student’s t -test. (b) Flow cytometric analysis of ABC level in ex vivo T reg s of healthy controls and MS patients (HC; n=14 subjects, MS; n=11 subjects). P value was calculated by two-sided Student’s t -test. Data were represented as mean +/− SD. (c-e) Correlation plots (c); between the percentage of IFN-γ−producing T reg cells and gMFI of Active β-catenin, (d); between IFNG and PTGER2 mRNA expression, (e); between Active β-catenin level and PTGER2 mRNA expression level in healthy subjects and MS patients. Linear regression is shown with 95% confidence interval (dotted lines). Correlation statistics by two-sided Spearman rank correlation test.

Article Snippet: Antibodies and reagents used for flow cytometric analysis are listed as follows: for human samples; anti-CD4 (RPA-T4), anti-CD25 (MA251), anti-CD127 (HIL-7R-M21), anti-CD45RO (UCHL1), anti-IFN-γ (B27), anti-β-catenin (14/Beta-Catenin), anti-TCF1 (S33–966), PE-Cy™7 Streptavidin from BD Bioscience, anti-IL-10 (JES3–9D7), anti-Tbet (4B10) from BioLegend, anti-phospho Foxo1 (S256) polyclonal, anti-phospho SGK1 (T256) polyclonal (from Bioss), anti-phospho β-catenin (Ser522) (D8E11), anti-phospho AKT (Ser473) (D9E), anti-phospho GSK3β (Ser9) (D85E12), anti-Foxo1 (C29H4) from CST, anti-IFN-γ (4S.B3), anti-Foxp3 (PCH101) from eBioscience, anti-active β-catenin (8E7) from Millipore, IFN-γ secretion assay (APC), IL-10 secretion assay (PE) from Miltenyi, for mice samples; anti-Foxp3 (FJK-16s), anti-CD3 (145–2C11), anti-CD4 (RM4–5), anti-CD8 (53–6.7), anti-GATA3 (TWAJ), anti-RORgt (B2D) from eBioscience, anti-Helios (22F6) from BioLegend, anti-phospho Foxo1 (S256) (E1F7T), anti-phospho Foxo3a (Ser253) (D18H8), anti-phospho Foxo1(T24)/3a(T32)/4(T28) (4G6) from CST, anti-SGK1 (Y238) (from Abcam), for both human and mice samples; Zombie Aqua™ Fixable Viability dye from BioLegend.

Techniques: Ex Vivo, Expressing

1,25(OH) 2 D 3 deficiency leads to increased gluconeogenesis and hepatic insulin resistance through impairing phosphorylation of AKT and phosphorylation of FOXO1. (a) ITT was performed in 6-month-old 1 α (OH)ase −/− and wild-type mice ( n = 8). ns: not significant; blue line: RDWT group; red line: RDKO group; black bar: RDWT group; gray bar: RDKO group. (b, c) Insulin stimulated the phosphorylation of AKT-S473 and FOXO1-S256 in wild-type livers markedly but failed to do so in the mutant ones, as measured by Western blotting (b) and IHC (c). ∗ P < 0.05. Scale bar = 100 μ m; magnification: 20x (c). (d) The phosphorylation of AKT-S473 and FOXO1-S256 was also inhibited in HepG2 cells transfected with si-VDR compared with HepG2 cells transfected with si-NC. ∗ P < 0.05. (e) Ectopic overexpression of FOXO1 increases transcriptional activity of PCK1 promoter. This effect was enhanced by knockdown of VDR. HepG2 cells were transfected with PCK1-luc, together with a FOXO1 expression vector (FOXO1) or a GFP expression vector as a control (GFP). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.

Journal: Journal of Diabetes Research

Article Title: Sirt1 Mediates Vitamin D Deficiency-Driven Gluconeogenesis in the Liver via mTorc2/Akt Signaling

doi: 10.1155/2022/1755563

Figure Lengend Snippet: 1,25(OH) 2 D 3 deficiency leads to increased gluconeogenesis and hepatic insulin resistance through impairing phosphorylation of AKT and phosphorylation of FOXO1. (a) ITT was performed in 6-month-old 1 α (OH)ase −/− and wild-type mice ( n = 8). ns: not significant; blue line: RDWT group; red line: RDKO group; black bar: RDWT group; gray bar: RDKO group. (b, c) Insulin stimulated the phosphorylation of AKT-S473 and FOXO1-S256 in wild-type livers markedly but failed to do so in the mutant ones, as measured by Western blotting (b) and IHC (c). ∗ P < 0.05. Scale bar = 100 μ m; magnification: 20x (c). (d) The phosphorylation of AKT-S473 and FOXO1-S256 was also inhibited in HepG2 cells transfected with si-VDR compared with HepG2 cells transfected with si-NC. ∗ P < 0.05. (e) Ectopic overexpression of FOXO1 increases transcriptional activity of PCK1 promoter. This effect was enhanced by knockdown of VDR. HepG2 cells were transfected with PCK1-luc, together with a FOXO1 expression vector (FOXO1) or a GFP expression vector as a control (GFP). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.

Article Snippet: Immunohistochemical staining for FOXO1 phosphorylated at S256, AKT phosphorylated at S473, and Sirt1 was carried out using the avidin-biotin-peroxidase complex technique with antibodies against FOXO1 phosphorylated at S256 (Cell Signaling Technology, #84192), AKT phosphorylated at S473 (Cell Signaling Technology, #4060), and Sirt1 (Abcam, #ab189494).

Techniques: Phospho-proteomics, Mutagenesis, Western Blot, Transfection, Over Expression, Activity Assay, Knockdown, Expressing, Plasmid Preparation, Control

Supplementation of 1,25(OH) 2 D 3 or overexpression of Sirt1 alleviates hepatic glucose overproduction and glucose metabolism disorders caused by 1,25(OH) 2 D 3 deficiency. (a) PTT performed in mice of different treatment groups. Blue line: RDWT group; red line: RDKO group; purple line: RD 1 α (OH)ase-/-SIRT1Tg group; green line: ND 1 α (OH)ase-/-+1,25(OH)2D3 group. (b) GTT performed in mice of different treatment groups. Blue line: RDWT group; red line: RDKO group; purple line: RD 1 α (OH)ase-/-SIRT1Tg group; green line: ND 1 α (OH)ase-/-+1,25(OH)2D3 group. (c) Expression levels of proteins including VDR, Sirt1, Rictor, PCK1, and G6PC collected from liver samples of mice of each group under normal feeding conditions. (d) Phosphorylation of AKT-S473 and FOXO1-S256 in the liver of mice stimulated with insulin. (e) VDR and Sirt1 protein expression levels in HepG2 cells treated with different concentrations of 1,25(OH) 2 D 3 or Sirt1 agonists (SRT1720HCL) were determined by Western blotting. (f) Glucose production content of HepG2 cells with knockdown of VDR or treated with 1,25(OH) 2 D 3 or SRT1720 HCL in response to pyruvate stimulation. ∗∗∗ P < 0.001; blue bar: si-NC group; red bar: si-VDR group; purple bar: 1,25(OH) 2 D 3 group; green bar: SRT1720HCL group. (g) Detection of mRNA expression of related genes in the liver of different treatment groups (qRT-PCR). ∗ P < 0.05. (h) Western blotting was performed to detect the expression levels of related proteins in different treatment groups of HepG2 cells. (i) The phosphorylation of AKT-S473 and FOXO1-S256 in HepG2 cell treated with different concentrations of 1,25(OH) 2 D 3 and Sirt1 agonist (SRT1720HCL) in response to insulin stimulation was measured by Western blotting.

Journal: Journal of Diabetes Research

Article Title: Sirt1 Mediates Vitamin D Deficiency-Driven Gluconeogenesis in the Liver via mTorc2/Akt Signaling

doi: 10.1155/2022/1755563

Figure Lengend Snippet: Supplementation of 1,25(OH) 2 D 3 or overexpression of Sirt1 alleviates hepatic glucose overproduction and glucose metabolism disorders caused by 1,25(OH) 2 D 3 deficiency. (a) PTT performed in mice of different treatment groups. Blue line: RDWT group; red line: RDKO group; purple line: RD 1 α (OH)ase-/-SIRT1Tg group; green line: ND 1 α (OH)ase-/-+1,25(OH)2D3 group. (b) GTT performed in mice of different treatment groups. Blue line: RDWT group; red line: RDKO group; purple line: RD 1 α (OH)ase-/-SIRT1Tg group; green line: ND 1 α (OH)ase-/-+1,25(OH)2D3 group. (c) Expression levels of proteins including VDR, Sirt1, Rictor, PCK1, and G6PC collected from liver samples of mice of each group under normal feeding conditions. (d) Phosphorylation of AKT-S473 and FOXO1-S256 in the liver of mice stimulated with insulin. (e) VDR and Sirt1 protein expression levels in HepG2 cells treated with different concentrations of 1,25(OH) 2 D 3 or Sirt1 agonists (SRT1720HCL) were determined by Western blotting. (f) Glucose production content of HepG2 cells with knockdown of VDR or treated with 1,25(OH) 2 D 3 or SRT1720 HCL in response to pyruvate stimulation. ∗∗∗ P < 0.001; blue bar: si-NC group; red bar: si-VDR group; purple bar: 1,25(OH) 2 D 3 group; green bar: SRT1720HCL group. (g) Detection of mRNA expression of related genes in the liver of different treatment groups (qRT-PCR). ∗ P < 0.05. (h) Western blotting was performed to detect the expression levels of related proteins in different treatment groups of HepG2 cells. (i) The phosphorylation of AKT-S473 and FOXO1-S256 in HepG2 cell treated with different concentrations of 1,25(OH) 2 D 3 and Sirt1 agonist (SRT1720HCL) in response to insulin stimulation was measured by Western blotting.

Article Snippet: Immunohistochemical staining for FOXO1 phosphorylated at S256, AKT phosphorylated at S473, and Sirt1 was carried out using the avidin-biotin-peroxidase complex technique with antibodies against FOXO1 phosphorylated at S256 (Cell Signaling Technology, #84192), AKT phosphorylated at S473 (Cell Signaling Technology, #4060), and Sirt1 (Abcam, #ab189494).

Techniques: Over Expression, Expressing, Phospho-proteomics, Western Blot, Knockdown, Quantitative RT-PCR

Model of mechanisms leading from 1,25(OH) 2 D 3 deficiency to increased hepatic gluconeogenesis. 1,25(OH) 2 D 3 -mediated pathway and insulin-mediated pathway converge on AKT, working together to promote AKT phosphorylation at Ser473 and then FOXO1 phosphorylation at Ser256. 1,25(OH) 2 D 3 deficiency suppresses Sirt1 expression, leading to downregulation of Rictor which further impaired phosphorylation of AKT-S473 and FOXO1-S256. As a result, the expression of G6Pase and PCK1 is upregulated, causing hepatic glucose overproduction and hepatic insulin resistance.

Journal: Journal of Diabetes Research

Article Title: Sirt1 Mediates Vitamin D Deficiency-Driven Gluconeogenesis in the Liver via mTorc2/Akt Signaling

doi: 10.1155/2022/1755563

Figure Lengend Snippet: Model of mechanisms leading from 1,25(OH) 2 D 3 deficiency to increased hepatic gluconeogenesis. 1,25(OH) 2 D 3 -mediated pathway and insulin-mediated pathway converge on AKT, working together to promote AKT phosphorylation at Ser473 and then FOXO1 phosphorylation at Ser256. 1,25(OH) 2 D 3 deficiency suppresses Sirt1 expression, leading to downregulation of Rictor which further impaired phosphorylation of AKT-S473 and FOXO1-S256. As a result, the expression of G6Pase and PCK1 is upregulated, causing hepatic glucose overproduction and hepatic insulin resistance.

Article Snippet: Immunohistochemical staining for FOXO1 phosphorylated at S256, AKT phosphorylated at S473, and Sirt1 was carried out using the avidin-biotin-peroxidase complex technique with antibodies against FOXO1 phosphorylated at S256 (Cell Signaling Technology, #84192), AKT phosphorylated at S473 (Cell Signaling Technology, #4060), and Sirt1 (Abcam, #ab189494).

Techniques: Phospho-proteomics, Expressing

Figure 1. FoxO1 expression in placentas of human and mouse. (A) FoxO1 immunohistochemistry staining in human term placenta. Red arrow: endothelial cells in villi; black arrow: cytotrophoblasts in villi; green arrow, spiral artery endothelial cells; yellow arrow, endometrial stromal cells. (B) Immunohistochemistry staining of FoxO1 in mice placentas at E10.5, E12.5, E14.5, E16.5, and term. Red lines indicate the borderline of different layers in the placenta; green arrows indicate FoxO1-positive signals. D, maternal decidua; JZ, junctional zone; LZ, labyrinth.

Journal: Laboratory investigation; a journal of technical methods and pathology

Article Title: FoxO1 Deficiency Enhances Cell Proliferation and Survival Under Normoglycemia and Promotes Angiogenesis Under Hyperglycemia in the Placenta.

doi: 10.1016/j.labinv.2022.100017

Figure Lengend Snippet: Figure 1. FoxO1 expression in placentas of human and mouse. (A) FoxO1 immunohistochemistry staining in human term placenta. Red arrow: endothelial cells in villi; black arrow: cytotrophoblasts in villi; green arrow, spiral artery endothelial cells; yellow arrow, endometrial stromal cells. (B) Immunohistochemistry staining of FoxO1 in mice placentas at E10.5, E12.5, E14.5, E16.5, and term. Red lines indicate the borderline of different layers in the placenta; green arrows indicate FoxO1-positive signals. D, maternal decidua; JZ, junctional zone; LZ, labyrinth.

Article Snippet: The antibodies against FoxO1 (2880), FoxO1 (phospho-S256) (9461), and CD31 (77699) were purchased from Cell Signaling Technology.

Techniques: Expressing, Immunohistochemistry, Staining

Figure 2. FoxO1 expression in human and mouse placentas under normal and hyperglycemic conditions. (A and B) FoxO1 immunohistochemistry staining performed in healthy women and those with GDM. (C) Staining intensity score in the placental villi. (D) Staining intensity score in the basal plate. (E) Western blot analysis of FoxO1 expression in E14.5 WT placentas under normal and hyperglycemic conditions. (F) Quantifications of the FoxO1:GAPDH ratio. Data are presented as the mean ± SE, N ¼ 4 to 5, *P < .05, **P < .01. GDM, gestational diabetes mellitus; HG, hyperglycemia; NG, normoglycemia.

Journal: Laboratory investigation; a journal of technical methods and pathology

Article Title: FoxO1 Deficiency Enhances Cell Proliferation and Survival Under Normoglycemia and Promotes Angiogenesis Under Hyperglycemia in the Placenta.

doi: 10.1016/j.labinv.2022.100017

Figure Lengend Snippet: Figure 2. FoxO1 expression in human and mouse placentas under normal and hyperglycemic conditions. (A and B) FoxO1 immunohistochemistry staining performed in healthy women and those with GDM. (C) Staining intensity score in the placental villi. (D) Staining intensity score in the basal plate. (E) Western blot analysis of FoxO1 expression in E14.5 WT placentas under normal and hyperglycemic conditions. (F) Quantifications of the FoxO1:GAPDH ratio. Data are presented as the mean ± SE, N ¼ 4 to 5, *P < .05, **P < .01. GDM, gestational diabetes mellitus; HG, hyperglycemia; NG, normoglycemia.

Article Snippet: The antibodies against FoxO1 (2880), FoxO1 (phospho-S256) (9461), and CD31 (77699) were purchased from Cell Signaling Technology.

Techniques: Expressing, Immunohistochemistry, Staining, Western Blot

Figure 3. FoxO1 expression in E14.5 WT and FoxO1þ/- placentas. (A) Western blot analysis of FoxO1 expression in placentas. (B) Quantifications of the FoxO1:GAPDH ratio. (C) Immu- nohistochemistry staining of FoxO1 in decidua and labyrinth of mouse placentas. Red arrows indicate representative FoxO1-positive signals. Data are presented as the mean ± SE, N ¼ 4 to 5, **P < .01. WT, wild-type.

Journal: Laboratory investigation; a journal of technical methods and pathology

Article Title: FoxO1 Deficiency Enhances Cell Proliferation and Survival Under Normoglycemia and Promotes Angiogenesis Under Hyperglycemia in the Placenta.

doi: 10.1016/j.labinv.2022.100017

Figure Lengend Snippet: Figure 3. FoxO1 expression in E14.5 WT and FoxO1þ/- placentas. (A) Western blot analysis of FoxO1 expression in placentas. (B) Quantifications of the FoxO1:GAPDH ratio. (C) Immu- nohistochemistry staining of FoxO1 in decidua and labyrinth of mouse placentas. Red arrows indicate representative FoxO1-positive signals. Data are presented as the mean ± SE, N ¼ 4 to 5, **P < .01. WT, wild-type.

Article Snippet: The antibodies against FoxO1 (2880), FoxO1 (phospho-S256) (9461), and CD31 (77699) were purchased from Cell Signaling Technology.

Techniques: Expressing, Western Blot, Staining

Figure 4. Embryonic and placental weight in WT and FoxO1þ/- mice under normal or hyperglycemic conditions at different gestational stages. (A) Embryo weight at E16.5. (B) Placenta weight at E16.5. (C) Embryo weight at term. (D) Placenta weight at term. (E) Litter size of the pregnancy. Data are presented as the mean ± SE, N ¼ 6 to 7, *P < .05. HG, hy- perglycemia; NG, normoglycemia; WT, wild-type.

Journal: Laboratory investigation; a journal of technical methods and pathology

Article Title: FoxO1 Deficiency Enhances Cell Proliferation and Survival Under Normoglycemia and Promotes Angiogenesis Under Hyperglycemia in the Placenta.

doi: 10.1016/j.labinv.2022.100017

Figure Lengend Snippet: Figure 4. Embryonic and placental weight in WT and FoxO1þ/- mice under normal or hyperglycemic conditions at different gestational stages. (A) Embryo weight at E16.5. (B) Placenta weight at E16.5. (C) Embryo weight at term. (D) Placenta weight at term. (E) Litter size of the pregnancy. Data are presented as the mean ± SE, N ¼ 6 to 7, *P < .05. HG, hy- perglycemia; NG, normoglycemia; WT, wild-type.

Article Snippet: The antibodies against FoxO1 (2880), FoxO1 (phospho-S256) (9461), and CD31 (77699) were purchased from Cell Signaling Technology.

Techniques:

Figure 5. FoxO1 deficiency increased relative labyrinth volume under normal conditions but not hyperglycemic conditions. (A) Immunohistochemistry staining of Tpbpa in placentas at E14.5. (B) Relative labyrinth volumes were evaluated using the ratio of the labyrinth area to the placenta area. (C) Relative junctional zone volumes were evaluated using the ratio of the junctional zone area to the placenta area. Data are presented as the mean ± SE, N ¼ 6 to 7, *P < .05. HG, hyperglycemia; NG, normoglycemia.

Journal: Laboratory investigation; a journal of technical methods and pathology

Article Title: FoxO1 Deficiency Enhances Cell Proliferation and Survival Under Normoglycemia and Promotes Angiogenesis Under Hyperglycemia in the Placenta.

doi: 10.1016/j.labinv.2022.100017

Figure Lengend Snippet: Figure 5. FoxO1 deficiency increased relative labyrinth volume under normal conditions but not hyperglycemic conditions. (A) Immunohistochemistry staining of Tpbpa in placentas at E14.5. (B) Relative labyrinth volumes were evaluated using the ratio of the labyrinth area to the placenta area. (C) Relative junctional zone volumes were evaluated using the ratio of the junctional zone area to the placenta area. Data are presented as the mean ± SE, N ¼ 6 to 7, *P < .05. HG, hyperglycemia; NG, normoglycemia.

Article Snippet: The antibodies against FoxO1 (2880), FoxO1 (phospho-S256) (9461), and CD31 (77699) were purchased from Cell Signaling Technology.

Techniques: Immunohistochemistry, Staining

Figure 6. FoxO1 disruption promoted proliferation and inhibited apoptosis under euglycemic conditions but not hyperglycemic conditions. (A) TUNEL staining in the labyrinth for placenta at E12.5. Red arrows indicate the cell with TUNEL-positive staining. (B) The number of TUNELþ cells per square micrometer in the labyrinth layer. (C) Relative expression levels of Casp2, Casp3, Casp8, Parp1, and Rip3 in the placenta at E12.5. (D) pH3S10 staining in the labyrinth of the placenta at E12.5. (E) The number of pH3S10þ cells per square micrometer in the labyrinth layer. (F) Relative expression levels of p21, p27, and Pten. Data are presented as the mean ± SE, N ¼ 4, *P < .05. HG, hyperglycemia; NG, normo- glycemia; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; WT, wild-type.

Journal: Laboratory investigation; a journal of technical methods and pathology

Article Title: FoxO1 Deficiency Enhances Cell Proliferation and Survival Under Normoglycemia and Promotes Angiogenesis Under Hyperglycemia in the Placenta.

doi: 10.1016/j.labinv.2022.100017

Figure Lengend Snippet: Figure 6. FoxO1 disruption promoted proliferation and inhibited apoptosis under euglycemic conditions but not hyperglycemic conditions. (A) TUNEL staining in the labyrinth for placenta at E12.5. Red arrows indicate the cell with TUNEL-positive staining. (B) The number of TUNELþ cells per square micrometer in the labyrinth layer. (C) Relative expression levels of Casp2, Casp3, Casp8, Parp1, and Rip3 in the placenta at E12.5. (D) pH3S10 staining in the labyrinth of the placenta at E12.5. (E) The number of pH3S10þ cells per square micrometer in the labyrinth layer. (F) Relative expression levels of p21, p27, and Pten. Data are presented as the mean ± SE, N ¼ 4, *P < .05. HG, hyperglycemia; NG, normo- glycemia; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; WT, wild-type.

Article Snippet: The antibodies against FoxO1 (2880), FoxO1 (phospho-S256) (9461), and CD31 (77699) were purchased from Cell Signaling Technology.

Techniques: Disruption, TUNEL Assay, Staining, Expressing

Figure 7. FoxO1 disruption promoted labyrinth angiogenesis. (A) Co-IF staining of PECAM (green) and cytokeratin (red) in the labyrinth, counterstained with DAPI (blue). (B) Relative fetal blood space (normalized to the WT-WT NG group) observed in a randomly selected 0.025-mm2 area. (C) Relative maternal lacunae space (normalized to the WT-WT NG group) observed in a randomly selected 0.025-mm2 area. (D) Western blot analysis of FoxO1 and p-FoxO1 expression in WT-WT, F-WT, and F-F placentas under normal or hyperglycemic conditions. (E) Western blot analysis of VEGFA and VEGFR2 expression in WT-WT and F-F placentas under normal or hyperglycemic conditions. (F) Relative expression levels of Eng and Tsp1 in the placenta at E14.5. Data are presented as the mean ± SE, N ¼ 6 to 7, *P < .05, **P < .01. HG, hyperglycemia; NG, normoglycemia; WT, wild-type.

Journal: Laboratory investigation; a journal of technical methods and pathology

Article Title: FoxO1 Deficiency Enhances Cell Proliferation and Survival Under Normoglycemia and Promotes Angiogenesis Under Hyperglycemia in the Placenta.

doi: 10.1016/j.labinv.2022.100017

Figure Lengend Snippet: Figure 7. FoxO1 disruption promoted labyrinth angiogenesis. (A) Co-IF staining of PECAM (green) and cytokeratin (red) in the labyrinth, counterstained with DAPI (blue). (B) Relative fetal blood space (normalized to the WT-WT NG group) observed in a randomly selected 0.025-mm2 area. (C) Relative maternal lacunae space (normalized to the WT-WT NG group) observed in a randomly selected 0.025-mm2 area. (D) Western blot analysis of FoxO1 and p-FoxO1 expression in WT-WT, F-WT, and F-F placentas under normal or hyperglycemic conditions. (E) Western blot analysis of VEGFA and VEGFR2 expression in WT-WT and F-F placentas under normal or hyperglycemic conditions. (F) Relative expression levels of Eng and Tsp1 in the placenta at E14.5. Data are presented as the mean ± SE, N ¼ 6 to 7, *P < .05, **P < .01. HG, hyperglycemia; NG, normoglycemia; WT, wild-type.

Article Snippet: The antibodies against FoxO1 (2880), FoxO1 (phospho-S256) (9461), and CD31 (77699) were purchased from Cell Signaling Technology.

Techniques: Disruption, Staining, Western Blot, Expressing

A : Pancreas sections stained for insulin (green) and glucagon (red). B-E : Bulk RNA sequencing of islets isolated from Control ( Irs2+/+ ; Cdk4 - wt/wt) , Diabetic (Irs2 - /- ; Cdk4 - wt/wt) , and Rescue ( Irs2 - /- ; Cdk4 - R24C/R24C) genotypes. Principal component analysis showed clean partitioning of the genotypes ( C ). K-means clustering ( D ) revealed three clusters in which mRNA abundance was disrupted during decompensation (Diabetic) and partially recovered in (Rescue). Cluster E, containing genes that were reduced in Irs2 - /- ; Cdk4 - wt/wt (Diabetic) mice and partially restored in Irs2 - /- ; Cdk4 - R24C/R24C (Rescue) mice, shown in the heat map in ( E ) mapped to a single GO term: Regulation of insulin secretion. F-H : Pancreas sections immunostained for insulin (green), dapi (blue) and ALDH1A3 ( F ), FOXO1 ( G ) or PDX1 ( H ) (red) confirm beta cell dedifferentiation signature in Irs2-/- male mice was rescued by homozygous Cdk4-R24C . Greyscale insets reflect red channel immunofluorescence in F-H .

Journal: bioRxiv

Article Title: Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting beta cell differentiation

doi: 10.1101/2022.10.19.512511

Figure Lengend Snippet: A : Pancreas sections stained for insulin (green) and glucagon (red). B-E : Bulk RNA sequencing of islets isolated from Control ( Irs2+/+ ; Cdk4 - wt/wt) , Diabetic (Irs2 - /- ; Cdk4 - wt/wt) , and Rescue ( Irs2 - /- ; Cdk4 - R24C/R24C) genotypes. Principal component analysis showed clean partitioning of the genotypes ( C ). K-means clustering ( D ) revealed three clusters in which mRNA abundance was disrupted during decompensation (Diabetic) and partially recovered in (Rescue). Cluster E, containing genes that were reduced in Irs2 - /- ; Cdk4 - wt/wt (Diabetic) mice and partially restored in Irs2 - /- ; Cdk4 - R24C/R24C (Rescue) mice, shown in the heat map in ( E ) mapped to a single GO term: Regulation of insulin secretion. F-H : Pancreas sections immunostained for insulin (green), dapi (blue) and ALDH1A3 ( F ), FOXO1 ( G ) or PDX1 ( H ) (red) confirm beta cell dedifferentiation signature in Irs2-/- male mice was rescued by homozygous Cdk4-R24C . Greyscale insets reflect red channel immunofluorescence in F-H .

Article Snippet: Antibodies include pFOXO1 S256 (#84192, Cell Signaling Technology), FOXO1 (#2280, Cell Signaling Technology), pSIRT1 (JJ206-6; Novus) and Actin (MAB1501; Sigma).

Techniques: Staining, RNA Sequencing, Isolation, Control, Immunofluorescence

A : Dispersed mouse islet cells starved for 16 hours (2mM glucose, 0% FBS) were fixed, immunostained for FOXO1 (red), insulin (green) and Dapi (blue), and imaged by confocal microscopy. B-G : Dispersed mouse islet cells were transduced with the indicated adenoviruses, cultured in islet complete media for 72 hours with some wells starved for the last 16 hours, then lysed and analyzed by qPCR. With control (Ad-cre) virus, starvation altered known FOXO1 target gene expression in the expected directions ( B ), decreased proliferation markers ( C ) and reduced expression of some beta cell differentiation genes ( D ). E-G: Transduction with CDK4 activators (Ad-Cdk4, Ad-CyclinD2, Ad-Cdk4+Ad-CyclinD2), or CDK4 inhibitor (Ad- p16) showed that activating CDK4 rescued abundance of proliferation markers ( E ), rescued 2 of 3 FOXO1 targets ( F ), and rescued Pdx1 and Neurod1 expression but not Mafa. Nkx6 . 1 and Ngn3 were not changed by starvation or CDK4 overexpression ( G ). Data in B-D are the controls from E-G , presented separately for clarity. H-I : Ad-Cdk4 or Ad-Cyclin D2 increased phosphorylation of FOXO1 in dispersed mouse islet cells exposed to starve conditions ( H ), but Ad-p16 did not, quantified in ( I ). Confocal microscopy ( J ) with quantification of the percent beta cells with nuclear FOXO1 showed nuclear FOXO1 was only variably reduced by CDK4 activation. Top and bottom panels show two different biological replicates illustrating variability of nuclear FOXO1 abundance. Greyscale panels represent red channel (FOXO1) immunofluorescence. Dashed lines represent mean starve control condition. Number of replicates is shown for each panel. Statistics by T-test ( B-D ) or one-way ANOVA ( E-I ) with Tukey post-test. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.

Journal: bioRxiv

Article Title: Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting beta cell differentiation

doi: 10.1101/2022.10.19.512511

Figure Lengend Snippet: A : Dispersed mouse islet cells starved for 16 hours (2mM glucose, 0% FBS) were fixed, immunostained for FOXO1 (red), insulin (green) and Dapi (blue), and imaged by confocal microscopy. B-G : Dispersed mouse islet cells were transduced with the indicated adenoviruses, cultured in islet complete media for 72 hours with some wells starved for the last 16 hours, then lysed and analyzed by qPCR. With control (Ad-cre) virus, starvation altered known FOXO1 target gene expression in the expected directions ( B ), decreased proliferation markers ( C ) and reduced expression of some beta cell differentiation genes ( D ). E-G: Transduction with CDK4 activators (Ad-Cdk4, Ad-CyclinD2, Ad-Cdk4+Ad-CyclinD2), or CDK4 inhibitor (Ad- p16) showed that activating CDK4 rescued abundance of proliferation markers ( E ), rescued 2 of 3 FOXO1 targets ( F ), and rescued Pdx1 and Neurod1 expression but not Mafa. Nkx6 . 1 and Ngn3 were not changed by starvation or CDK4 overexpression ( G ). Data in B-D are the controls from E-G , presented separately for clarity. H-I : Ad-Cdk4 or Ad-Cyclin D2 increased phosphorylation of FOXO1 in dispersed mouse islet cells exposed to starve conditions ( H ), but Ad-p16 did not, quantified in ( I ). Confocal microscopy ( J ) with quantification of the percent beta cells with nuclear FOXO1 showed nuclear FOXO1 was only variably reduced by CDK4 activation. Top and bottom panels show two different biological replicates illustrating variability of nuclear FOXO1 abundance. Greyscale panels represent red channel (FOXO1) immunofluorescence. Dashed lines represent mean starve control condition. Number of replicates is shown for each panel. Statistics by T-test ( B-D ) or one-way ANOVA ( E-I ) with Tukey post-test. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.

Article Snippet: Antibodies include pFOXO1 S256 (#84192, Cell Signaling Technology), FOXO1 (#2280, Cell Signaling Technology), pSIRT1 (JJ206-6; Novus) and Actin (MAB1501; Sigma).

Techniques: Confocal Microscopy, Transduction, Cell Culture, Control, Virus, Targeted Gene Expression, Expressing, Cell Differentiation, Over Expression, Phospho-proteomics, Activation Assay, Immunofluorescence

A : Dispersed mouse islet cells cultured in ICM with 15mM glucose were treated with nuclear export inhibitor Leptomycin B (100nM) for the indicated duration, then fixed, immunostained for insulin (green), FOXO1 (red) and DAPI (blue), and imaged by confocal microscopy. The red (FOXO1) channel is displayed separately below. B- C : Dispersed mouse islet cells treated with Leptomycin B for 24 hours were analyzed by qPCR for FOXO1 targets ( B ) or beta cell maturation genes ( C ). D-F : Dispersed mouse islet cells cultured in ICM with 15mM glucose were treated with AKT inhibitor MK-2206 (5uM) for the indicated durations, then fixed, immunostained as above, and imaged on a standard fluorescence microscope ( D ) or lysed for qPCR (72h) ( E-F ). ( A ) and ( D ) are representative images; number of replicates is shown for all other panels. Statistics ( B, C, E, F ) are by unpaired T-test. *p<0.05, **p<0.01.

Journal: bioRxiv

Article Title: Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting beta cell differentiation

doi: 10.1101/2022.10.19.512511

Figure Lengend Snippet: A : Dispersed mouse islet cells cultured in ICM with 15mM glucose were treated with nuclear export inhibitor Leptomycin B (100nM) for the indicated duration, then fixed, immunostained for insulin (green), FOXO1 (red) and DAPI (blue), and imaged by confocal microscopy. The red (FOXO1) channel is displayed separately below. B- C : Dispersed mouse islet cells treated with Leptomycin B for 24 hours were analyzed by qPCR for FOXO1 targets ( B ) or beta cell maturation genes ( C ). D-F : Dispersed mouse islet cells cultured in ICM with 15mM glucose were treated with AKT inhibitor MK-2206 (5uM) for the indicated durations, then fixed, immunostained as above, and imaged on a standard fluorescence microscope ( D ) or lysed for qPCR (72h) ( E-F ). ( A ) and ( D ) are representative images; number of replicates is shown for all other panels. Statistics ( B, C, E, F ) are by unpaired T-test. *p<0.05, **p<0.01.

Article Snippet: Antibodies include pFOXO1 S256 (#84192, Cell Signaling Technology), FOXO1 (#2280, Cell Signaling Technology), pSIRT1 (JJ206-6; Novus) and Actin (MAB1501; Sigma).

Techniques: Cell Culture, Confocal Microscopy, Fluorescence, Microscopy

A-D : Dispersed mouse islet cells were transduced with Ad-LacZ control, Ad-FOXO1, and/or Ad-CDK4 with Ad-Cyclin D2, cultured for 72 hours in ICM with 15mM glucose, then analyzed by qPCR for ( A ) hCDK4 or Foxo1 to assess transduction, ( B ) FOXO1 targets, or ( C ) beta cell differentiation genes; ( D ) parallel cultures on glass coverslips were immunostained for insulin (green), FOXO1 (red) and DAPI (blue) to assess FOXO1 localization in beta cells. E-G : Dispersed mouse islet cells were transduced with Ad-LacZ (control), Ad-FOXO1-ADA (unphosphorylatable mutant), and Ad-CDK4 + Ad-Cyclin D2, cultured for 72 hours in ICM with 15mM glucose, and subjected to ( E ) immunostaining for insulin (green), FOXO1 (red) and DAPI (blue) to assess FOXO1 localization in beta cells, or qPCR for ( F ) FOXO1 targets or ( G ) beta cell differentiation genes. H : Dispersed mouse islet cells transduced with the indicated adenoviruses for 72 hours in ICM with 15mM glucose were lysed for qPCR for E2f1 or Pdx1 . Number of replicates is shown for all qPCR panels. Statistics are by one-way ANOVA with Tukey post-test, *p<0.05.

Journal: bioRxiv

Article Title: Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting beta cell differentiation

doi: 10.1101/2022.10.19.512511

Figure Lengend Snippet: A-D : Dispersed mouse islet cells were transduced with Ad-LacZ control, Ad-FOXO1, and/or Ad-CDK4 with Ad-Cyclin D2, cultured for 72 hours in ICM with 15mM glucose, then analyzed by qPCR for ( A ) hCDK4 or Foxo1 to assess transduction, ( B ) FOXO1 targets, or ( C ) beta cell differentiation genes; ( D ) parallel cultures on glass coverslips were immunostained for insulin (green), FOXO1 (red) and DAPI (blue) to assess FOXO1 localization in beta cells. E-G : Dispersed mouse islet cells were transduced with Ad-LacZ (control), Ad-FOXO1-ADA (unphosphorylatable mutant), and Ad-CDK4 + Ad-Cyclin D2, cultured for 72 hours in ICM with 15mM glucose, and subjected to ( E ) immunostaining for insulin (green), FOXO1 (red) and DAPI (blue) to assess FOXO1 localization in beta cells, or qPCR for ( F ) FOXO1 targets or ( G ) beta cell differentiation genes. H : Dispersed mouse islet cells transduced with the indicated adenoviruses for 72 hours in ICM with 15mM glucose were lysed for qPCR for E2f1 or Pdx1 . Number of replicates is shown for all qPCR panels. Statistics are by one-way ANOVA with Tukey post-test, *p<0.05.

Article Snippet: Antibodies include pFOXO1 S256 (#84192, Cell Signaling Technology), FOXO1 (#2280, Cell Signaling Technology), pSIRT1 (JJ206-6; Novus) and Actin (MAB1501; Sigma).

Techniques: Transduction, Control, Cell Culture, Cell Differentiation, Mutagenesis, Immunostaining